Clinical Trial Update: Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether omega-3 supplementation affects biomarkers of cardiac injury (CK-MB and troponin I) and inflammation (CRP) after elective PCI. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Coronary Arteriosclerosis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-09